These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 31007749)
21. Outcomes and Durability of Hepatic Reduction after Combined Partial Hepatectomy and Cyst Fenestration for Massive Polycystic Liver Disease. Chebib FT; Harmon A; Irazabal Mira MV; Jung YS; Edwards ME; Hogan MC; Kamath PS; Torres VE; Nagorney DM J Am Coll Surg; 2016 Jul; 223(1):118-126.e1. PubMed ID: 27016902 [TBL] [Abstract][Full Text] [Related]
22. Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation. Kirchner GI; Rifai K; Cantz T; Nashan B; Terkamp C; Becker T; Strassburg C; Barg-Hock H; Wagner S; Lück R; Klempnauer J; Manns MP Liver Transpl; 2006 Aug; 12(8):1268-77. PubMed ID: 16741930 [TBL] [Abstract][Full Text] [Related]
23. Questionnaire PLD-complaint-specific assessment identifies need for therapy in polycystic liver disease: A multi-centric prospective study. Billiet A; Temmerman F; Coudyzer W; Van den Ende N; Colle I; Francque S; De Maeght S; Janssens F; Orlent H; Sprengers D; Delwaide J; Decock S; De Vloo C; Moreno C; van Malenstein H; van der Merwe S; Verbeek J; Nevens F United European Gastroenterol J; 2023 Sep; 11(7):633-641. PubMed ID: 37278135 [TBL] [Abstract][Full Text] [Related]
24. Impact of liver volume on polycystic liver disease-related symptoms and quality of life. Neijenhuis MK; Kievit W; Verheesen SM; D'Agnolo HM; Gevers TJ; Drenth JP United European Gastroenterol J; 2018 Feb; 6(1):81-88. PubMed ID: 29435317 [TBL] [Abstract][Full Text] [Related]
25. Center is an important indicator for choice of invasive therapy in polycystic liver disease. D'Agnolo HM; Kievit W; van Munster KN; van der Laan JJ; Nevens F; Drenth JP Transpl Int; 2017 Jan; 30(1):76-82. PubMed ID: 27732751 [TBL] [Abstract][Full Text] [Related]
27. Treatment of highly symptomatic polycystic liver disease. Preliminary experience with a combined hepatic resection-fenestration procedure. Newman KD; Torres VE; Rakela J; Nagorney DM Ann Surg; 1990 Jul; 212(1):30-7. PubMed ID: 2363601 [TBL] [Abstract][Full Text] [Related]
28. Combined liver-kidney transplantation for polycystic liver and kidney disease: analysis from the United Network for Organ Sharing dataset. Coquillard C; Berger J; Daily M; Shah M; Mei X; Marti F; Gedaly R Liver Int; 2016 Jul; 36(7):1018-25. PubMed ID: 26663575 [TBL] [Abstract][Full Text] [Related]
29. Multicentric Study of the Andalusian Experience in Polycystic Liver Disease as Indication for Liver Transplantation. Dios-Barbeito S; Domínguez-Bastante M; Moreno-Navas A; León-Díaz FJ; Fundora-Suárez Y; Briceño-Delgado FJ; Pitarch-Martínez M; Gómez-Bravo MÁ Transplant Proc; 2018 Mar; 50(2):613-616. PubMed ID: 29579867 [TBL] [Abstract][Full Text] [Related]
32. Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease. Kim H; Park HC; Ryu H; Kim K; Kim HS; Oh KH; Yu SJ; Chung JW; Cho JY; Kim SH; Cheong HI; Lee K; Park JH; Pei Y; Hwang YH; Ahn C PLoS One; 2015; 10(12):e0144526. PubMed ID: 26641645 [TBL] [Abstract][Full Text] [Related]
33. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175 [TBL] [Abstract][Full Text] [Related]
34. Combined Liver-Kidney Transplantation in Children: Single-Center Experiences and Long-Term Results. Szymczak M; Kaliciński P; Kowalewski G; Markiewicz-Kijewska M; Broniszczak D; Ismail H; Stefanowicz M; Kowalski A; Rubik J; Jankowska I; Piątosa B; Teisseyre J; Grenda R Transplant Proc; 2018 Sep; 50(7):2140-2144. PubMed ID: 30177126 [TBL] [Abstract][Full Text] [Related]
35. Intensive care unit outcomes following orthotopic liver transplantation: single-center experience and review of the literature. Damaskos C; Kaskantamis A; Garmpis N; Dimitroulis D; Mantas D; Garmpi A; Sakellariou S; Angelou A; Syllaios A; Kostakis A; Lampadariou E; Floros I; Revenas K; Antoniou EA G Chir; 2019; 40(6):463-480. PubMed ID: 32007108 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of 4 Years of Octreotide Long-Acting Release Therapy in Patients With Severe Polycystic Liver Disease. Hogan MC; Masyuk T; Bergstralh E; Li B; Kremers WK; Vaughan LE; Ihrke A; Severson AL; Irazabal MV; Glockner J; LaRusso NF; Torres VE Mayo Clin Proc; 2015 Aug; 90(8):1030-7. PubMed ID: 26166166 [TBL] [Abstract][Full Text] [Related]
37. Transarterial Embolization for Treatment of Symptomatic Polycystic Liver Disease: More than 2-year Follow-up. Zhang JL; Yuan K; Wang MQ; Yan JY; Xin HN; Wang Y; Liu FY; Bai YH; Wang ZJ; Duan F; Fu JX Chin Med J (Engl); 2017 Aug; 130(16):1938-1944. PubMed ID: 28776546 [TBL] [Abstract][Full Text] [Related]
38. Current treatment status of polycystic liver disease in Japan. Ogawa K; Fukunaga K; Takeuchi T; Kawagishi N; Ubara Y; Kudo M; Ohkohchi N Hepatol Res; 2014 Oct; 44(11):1110-8. PubMed ID: 24308726 [TBL] [Abstract][Full Text] [Related]